NCT05223608 2026-03-18
ImmuCCo
Centre Oscar Lambret
Phase NA Recruiting
Clinical Trials
975 trialsNCT07480733 2026-03-18
A Phase II Clinical Study Evaluating the Safety, Tolerability,Pharmacokinetics, and Preliminary Efficacy of JS212 andJS213 as Monotherapy and in Combination in Patients Withadvanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Not yet recruiting
NCT05023655 2026-03-17
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
Prisma Health-Upstate
Phase 2 Terminated
NCT06927297 2026-03-17
Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors
West China Hospital
Phase 1 Recruiting
NCT06840834 2026-03-16
Bi-MAPS
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Recruiting
NCT06565260 2026-03-13
Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors
Roswell Park Cancer Institute
Phase NA Recruiting
NCT06771739 2026-03-13
A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial
Fred Hutchinson Cancer Center
Phase NA Not yet recruiting
NCT07469982 2026-03-13
A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors
Shouyao Holdings (Beijing) Co. LTD
Phase 1 Not yet recruiting
NCT05238792 2026-03-12
Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors
Children's National Research Institute
Phase 1 Recruiting
NCT06563375 2026-03-12
Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT03074513 2026-03-11
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04870788 2026-03-11
Mindfulness-Based Intervention for Latino Cancer Patients and Their Caregivers
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT06367751 2026-03-11
LIQPLAT
University Hospital, Basel, Switzerland
Phase NA Active not recruiting
NCT07018622 2026-03-11
DAPA-ARMOR
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phase 2 Recruiting
NCT07459920 2026-03-10
CAPTURE
National Cancer Institute, Naples
Phase 2 Not yet recruiting
NCT07461181 2026-03-10
A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors
Ruijin Hospital
Phase 1/2 Active not recruiting
NCT01761929 2026-03-06
5fr SBRT
University Health Network, Toronto
Phase 2 Completed
NCT02959463 2026-03-06
Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT05661201 2026-03-06
NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors
Georgetown University
Phase 1 Recruiting
NCT00797719 2026-03-05
Short Neoadjuvant Hemithoracic IMRT for MPM
University Health Network, Toronto
Phase 1/2 Completed
NCT02701712 2026-03-05
MRgRT
University Health Network, Toronto
Phase NA Active not recruiting
NCT04028570 2026-03-05
SMARTER
University Health Network, Toronto
Phase NA Active not recruiting
NCT04928508 2026-03-05
Okgyn1
University of Oklahoma
Phase 1 Recruiting
NCT06279130 2026-03-05
NEOASIS
The Netherlands Cancer Institute
Phase 2/3 Recruiting
NCT05436093 2026-03-04
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Phase NA Recruiting
NCT07059884 2026-03-04
DEFEND
Alliance for Clinical Trials in Oncology
Phase NA Recruiting
NCT07450352 2026-03-04
SEED-CRYO: Sequential 125I Seed Implantation Followed by Cryoablation vs Single-Modality Local Therapy in Unresectable Solid Tumors
Jinan Military General Hospital
Phase 2 Not yet recruiting
NCT03420963 2026-03-03
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT07365007 2026-03-03
A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment
University of Michigan Rogel Cancer Center
Phase NA Recruiting
NCT07446725 2026-03-03
A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors
Suzhou Genhouse Bio Co., Ltd.
Phase 1/2 Not yet recruiting
NCT06612645 2026-03-02
CMD03
Chulalongkorn University
Phase 1 Recruiting
NCT07443020 2026-03-02
RIOT 4B
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase 1 Not yet recruiting
NCT06945380 2026-02-27
Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy
Mayo Clinic
Phase NA Recruiting
NCT07437625 2026-02-27
Lesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic Disease
Jinan Military General Hospital
Phase 2 Not yet recruiting
NCT07438093 2026-02-27
Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors
The First Affiliated Hospital of Xiamen University
Phase NA Not yet recruiting
NCT05645523 2026-02-25
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
St. Jude Children's Research Hospital
Phase EARLY_PHASE1 Recruiting
NCT06484595 2026-02-25
GUIDE
Fred Hutchinson Cancer Center
Phase NA Completed
NCT07126496 2026-02-23
A Virtual Community Health Educator for Increasing Clinical Trial Referrals Among Cancer Patients and Their Caregivers
Mayo Clinic
Phase NA Recruiting
NCT07420010 2026-02-19
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT06827054 2026-02-18
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Roswell Park Cancer Institute
Phase 2 Not yet recruiting
NCT07417501 2026-02-18
Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification
Tongji Hospital
Phase 2 Not yet recruiting
NCT05100251 2026-02-17
Clinical Trial of WBC100 on Advanced Solid Tumor
Zhejiang University
Phase 1 Terminated
NCT06629584 2026-02-17
Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06651593 2026-02-17
Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06279013 2026-02-13
SYMON
NRG Oncology
Phase NA Recruiting
NCT07220447 2026-02-12
L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
City of Hope Medical Center
Phase EARLY_PHASE1 Recruiting
NCT07225920 2026-02-12
PGA
Wake Forest University Health Sciences
Phase NA Enrolling by invitation
NCT07407985 2026-02-12
GK01IIT-TZ03
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Active not recruiting
NCT06598371 2026-02-11
A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT07234058 2026-02-11
LAG-MAPS
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Not yet recruiting